CIMS Fever Clinic

CIMS Fever Clinic

JCI

JCI

Isolation Unit

Isolation Unit

CIMS BREAST CANCER

CIMS BREAST CANCER

Global Healthcare Excellence Award 2018

Global Healthcare Excellence Award 2018

Diabetes Check

Diabetes Check

Dr Satya Gupta

Name:                         Dr. Satya Gupta

Sex:                            Male

Date of Birth:            21st May 1970

Address:                    Office:

Care Institute of Medical Science (CIMS)

Off Science City Road, Opp Sukan Mall

Near Sola Bridge

Ahmedabad-380 054, India

Phone: +91-79-27712771(1-5 lines)

Fax :    +91-79-27712770

Email:                       satya.gupta@cims.me, stya.gupta@gmail.com

 

CURRENT AFFILIATION:

Consultant and Interventional Cardiologist at CIMS hospital Ahmedabad

Qualification College / University Year
FIC (Cardiology)

 

 

DM (Cardiology)

 

MD(Internal medicine)

 

Internship

 

MBBS

 

USMLE

Pitie-Salpetriere University Hospital, Paris

 

Christian Medical College, Vellore,

 

University of Rajasthan, Jaipur

 

University of Rajasthan, Jaipur

 

University of Rajasthan, Jaipur

 

ECFMG, Philadelphia, USA

July 2006

 

 

August 2005

 

June 1999

 

Mar1994 – Feb 1995

 

Feb 1994

 

Passed in 1996

Work Experience:

  • Fellow in Interventional Cardiology: PITIE-SALPETRIERE University Hospital Paris, France – Nov 2005 – June 2006. 
  • Clinical Visiting Scientist for Multislice CT angiography and Intravascular Ultrasound: Cardiovascular Center Aalst, OLV Ziekenhus, Aalst, Belgium – 6th – 16th    June 2006. 
  • DM Trainee and Tutor in CardiologyChristian Medical College Hospital, Vellore – since January 2002- Oct 2005.
  • Senior RegistrarDept. Of cardiology – Christian Medical College Hospital, Vellore – February 2000 – January 2002
  • Senior RegistrarJaslok Hospital and Research Center, Mumbai –         August 1999 – November 1999
  • Registrar –  Dept. of Medicine – Dr. S.N Medical College, Jodhpur –              March 1996 – June 1999
  • Medical officer – Kamla Nagar Hospital, Jodhpur – March 1995- February 1996

 

Publications: (Index Jour)

  • “Impact of anticoagulation on Ionic and Non Ionic Contrast Media effect on thrombogenesis and fibrinolysis: The PEPCIT Study” Sent to Arteriosclerosis, Thrombosis and Vascular Biology Journal for publication. 
  • Trans-radial Interventions: Our Experience. Indian Heart J 2010; 62:264-266. 
  • Tips and Tricks for Radial Interventions. Indian Heart J 2010; 62:275-276.
  • Recanalization of single functioning kidney (Case report). Indian Heart J 2005; 57:741-743.
  • Mortality and morbidity due to acute ST segment elevation myocardial infarction in the current era. Indian Heart J 2004; 56:210-214.
  • Prevalence of coronary artery disease in patients with rheumatic heart disease. Indian Heart J 2004; 56:129-131.
  • Blood filled cysts of heart. Indian Heart J 2004; 56:174-175.
  • Heart failure: What proportion of patients satisfies the Electrocardiographic criteria for cardiac resynchronization therapy? Indian Heart J 2003; 55:619-623.
  • Utility of N-Terminal Pro BNP in the diagnosis of heart failure. Indian Heart J 2003; 55:35-39.
  • Affect of plasmodium falciparum and plasmodium vivax infection on renal functions. SDMH Jour (ISSN 0970-0390) 1998; 22:53-58
  • Pulmonary Pulsus Alternans: An Unusual pulmonary haemodynamic phenomenon in patients with mitral stenosis. Sent to Cathet Cardiovasc Interv for publication.

Presentations in Conferences:

  • Effect of ionic and non ionic constrast media on thrombegenis and fibrinolysis depends on anticoagulation regimens. Presented at European society of cardiology conference, Vienna, Austria on 4rd Sept 2007. European Heart Journal (2007 ) 28 ( Abstract Supplement ), 665. http://spo.escardio.org/abstract-book/presentation.aspx?id=52919
  • Profile of Myocardial Infarction in Young Indian Patients. Indian Heart J 2004; 56:406.
  • In-hospital mortality and complications due to acute STEMI in patients with previous myocardial infarction. Indian Heart J 2004; 56:406.
  • Profile of coronary artery disease in Indian women. Indian Heart J 2004; 56:407.
  • Target lipid levels and Statins. Indian Heart J 2004; 56:557.
  • Comparison of echocardiographic left ventricular dimension with plasma levels of NTpro BNP. Presented at 9th Annual conference of Indian academy of echocardiography and international conference on advances in cardiology. 13th-15th Feb 2004, Bhubaneswar.
  • In hospital mortality and 30-day events in patients with acute STEMI presenting to a tertiary care center. Indian Heart J 2003;55:462
  • Role of NTpro BNP for the diagnosis of LV systolic and diastolic dysfunction. Indian Heart J 2003;55:466
  • Cutting balloon angioplasty of obstructive lesions in Takayasu’s arteritis yields exceptional results. Indian Heart J 2003;55:476
  • Frequency of angiographic ally significant CAD in patients with RHD. Indian Heart J 2003; 55:578
  • Components of pre-hospital delay in acute myocardial infarction. Indian Heart Journal 2002; 54:481.
  • Utility of N-Terminus of the Precursor Brain Natriuretic Peptide in identifying left ventricular dysfunction. Indian Heart Journal 2002; 54:559.
  • Gender differences in exercise electrocardiogram using Bruce Protocol. Indian Heart Journal 2002; 54:626.
  • Renal artery involvement in patients with coronary artery disease. Indian Heart Journal 2001; 53:573.
  • Serum Troponin –T in the diagnosis of acute myocardial infarction and its comparison with CPKMB. [Presented at IX annual conference, Association of Physician of India, (Rajasthan Chapter) 1998]
  • “Liver involvement in falciparum malaria” A biochemical and histopathological analysis. 54th Joint Annual National Conference of association of physician of India. JAPI 1999; 47:27.

 

Conferences Attended:

  • 5 Days Hands on workshop for complex PCI at Marseille France, July 2011.
  • European Society of Cardiology Conference. 2009 Aug29-2 Sept, Barcelona, Spain.
  • The 5th World Congress of Pediatric Cardiology and Cardiac Surgery. 2009 June 21-26, Cairns, Australia.
  • European Society of Cardiology Conference. 2008 Sept 1-4, Munich, Germany.
  • Annual Conference of Pediatric Cardiac Society of India. 2004, 2008.
  • Kamakura Live Radial Workshop, Yokohama, Japan, Dec 2007.
  • Newer Advances in Interventional Cardiology. Symposium at Kuala Lumpur, Malaysia 23-26 June 2007
  • World Congress of Cardiology 2006 and Joint Meeting of European Society of Cardiology & World Heart Federation, 2-6th Sept, Barcelona, Spain.
  • EuroPCR 2006, 16-19th May 2006, Paris, France.
  • Thrombosis & Urgences Coronaires, 30-31st March Paris, France.
  • French Society of Intervention Cardiology Congress( High Tech 2006), 25-27th Jan 2006, Marseille, France.
  • CSI, Annual Conference:- 2001,2002,2003,2004,2008.

Work experience in Cardiology:

After finishing MD in internal medicine I worked at Jaslok Hospital and Research Center Mumbai, which is one of the premier hospitals of India. During this period I was exposed to manage critically ill patients and learned the interventional procedures require managing such patients.

In February 2000, I joined Department of Cardiology, Christian Medical College and Hospital Vellore, as a Senior Registrar. This period involved training and care of adult and pediatric cardiac patients. Apart from supervised care of out and inpatients, it also involved management of patients in cardiac care unit, performing special investigations like treadmill stress testing.

Subsequently, I joined the same institute as a DM trainee in Cardiology under MGR Medical University. This 3 year period involve care of out and inpatients, performing special investigations independently viz. treadmill stress test, holter analysis, echocardiography, cardiac catheterization and interventions. During active posting in cardiac catheterization lab for 7 months, I was doing various diagnostic cardiac catheterization procedures independently and assisted various cardiac interventions.

While going through basic cardiology training, I realized that cardiology is vast and I discovered that, I am more comfortable and competent in doing the interventional procedures as well as I find my inclination toward academics. To further my knowledge in the academics and interventions, I selected PITIE-SALPETRIERE University Hospital Paris (France) as my destination to advance my career.

Pitie-Salpetriere is the largest and oldest Hospital (founded in 1613) in Europe till date. Here I had honor to work with Dr Gilles Montalescot who is renowned for his contribution in the field of cardiology. Dr Gilles trained me for radial angiograms and angioplasties and also participated in ongoing multinational research projects. I performed hundreds of radial angiograms and angioplasties independently under the guidance of Prof Gilles Montalescot.

In July 2006, I joined the leading cardiac group in Ahmedabad which is know for providing best cardiac services in the country. I was also affiliated with V S General Hospital as a consultant cardiologist from July 2006 to August 2008. I am performing all cardiac procedure independently, confidently and sincerely because of the excellent training I received from masters in the field of cardiology. Details of cardio logical procedures performed by me as on 31st August 2010 are as follow.

INTERNATIONAL CLINICAL TRIALS: 

1 Co Investigator for Hypercholesterol study (NK-104-301) at The Heart Care Clinic/CIMS (2005) Study of Pitavastatin 2 mg vs. Atorvastatin 10 mg and Pitavastatin 4 mg vs. Atorvastatin 20 mg (Following Up Titration ) in Patients with Primary Hypercholesterolemia Or Combined Dyslipidemia Trial completed
2 Co  Investigator for Neovasc Reducer™ Pilot Study, First in human: (2005) To evaluate the safety of the Neovasc Reducer™ in the treatment of Ischemic heart Disease (IHD), controlled narrowing of the coronary sinus Presented at TCT, 2005
3 Co Investigator For PAPIRUS Trial: Pilot Study, First in Human: Apollo Hospital (2005) Monitoring Pulmonary Artery Pressure by Implantable Device Responding to Ultrasonic Signal (REMON Device) Trial completed
4 Co Investigator for Export study (2006) Flow improvement in patients with Acute Myocardial Infarction undergoing either conventional stenting or a strategy of primary aspiration followed by stenting using the Export® Aspiration Catheter: a Prospective, Randomized, Controlled Study

 

Trial completed
5 Co l Investigator for E-five registry (for India) (2006) To Evaluate the ‘Real World’ Clinical Performance of the Medtronic Endeavor™ ABT-578 Eluting Coronary Stent System.

 

Trial completed
6 Co- Investigator for RELY study (2006) Randomized Evaluation of Long term anticoagulant therapy comparing efficacy and safety of two blinded doses of dabigatran etiolate with open label warfarin for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: prospective, multi-centre, Parallel group, non-inferiority trial.

 

Trial completed

 

7 Co-Investigator for Hypercholesterolemia study (NK-104-307) at The Heart Care Clinic/CIMS (2006) Open label, long-Term (1year) extension study of Pitavastatin 4 mg QD in patients with Primary Hypercholesterolemia or combined Dyslipidemia Trial completed
8 Co-Investigator for

e-SELECT Registry (2007)

The e-SELECT Registry: A Multicenter Post Marketing Survelliance  Trial completed, follow-ups ongoing
9 Co-Investigator for Early ACS trial (2007) Early Glycoprotein Iib/IIIa Inhibition in Non-ST-segment Elevation Acute Coronary Syndrome: A Randomized, Placebo-Controlled Trial Evaluating the Clinical Benefits of Early Front-loaded  Eptifibatide in the Treatment of Patients with Non-ST-segment Elevation Acute Coronary Syndrome (EARLY ACS) Follow-ups ongoing
10 Co-Investigator for PLATO trial (2007). A Randomized, Double-blind, Parallel Group, Phase 3, Efficacy and safety study of AZD6140 Compares with Clopidogrel for prevention of Vascular Events in patients with Non-ST or ST Elevation Acute Coronary Syndromes (ACS) [PLATO – A study of Platelet inhibition and Patient Outcomes.] Trial completed
11 Co-Investigator for OASIS- 7 trial (2007) Randomized, multinational, double-blind study, comparing a high loading dose regimen of Clopidogrel versus standard dose in patients with unstable angina or non-ST segment elevation myocardial infarction managed with an early invasive strategy Trial completed

 

 

12 Co-Investigator for New Guide wire (2007) First in Man: A Feasibility study to evaluate safety and efficacy of New Guide wire for Crossing Total Occlusions in Coronary Arteries Trial completed

 

13 Co-Investigator for Paediatric Hypertension Trial, The Heart Care Clinic/CIMS, Ahmedabad (2007) A Randomized, double blind, Placebo-Controlled, Multicenter, Parallel Study Assessing the Efficacy, Safety, and Dose Response of Ramipril for the Treatment of Hypertension in Children and Adolescents Trial completed

 

14 Co-Investigator for Aristotle Trial at The Heart Care Clinic/CIMS, Ahmedabad (2007) Apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation: Active controlled randomized double blind parallel  arm study to evaluate efficacy and safety of Apixaban in subject with  non valvular Atrial fibrillation Ongoing

 

15 Co-Investigator for Rocket Trial at The Heart Care Clinic/CIMS, Ahmedabad (2007) Multicenter, Randomized, double-blind – dummy, Parallel-group, Non-inferiority Trial Comparing the Efficacy and Safety of Once-daily oral Rivaroxabab (BAY 59-7939) with Adjusted-dose oral Warfarin for the prevention of Stroke and Non-central-nervous-system systemic embolism in Subjects with Non-valvular Atrial Fibrillation       Ongoing
16 Co-Investigator for PROTECT Trial (2007) Patient Related Outcomes with Endeavor versus Cypher stenting Trial: Prospective, multicenter, randomized, two-arm, open-label trial Follow-ups ongoing
17 Co-Investigator for TMC-CAN-05-02 (2007) A clinical trial comparing Cangrelor to Clopidogrel in subject who require Percutaneous Coronary Intervention Follow-ups ongoing
18 Co-Investigator for TMC-CAN-05-03 (2008) A clinical Trial comparing treatment with Cangrelor (in combination with usual care) to usual care in subjects who require Percutaneous Coronary Intervention Follow-ups ongoing
19 Co-Investigator for CL  (Ivabradine) at The Heart Care Clinic/CIMS (2008) Evaluation of the anti-anginal efficacy Ongoing
20 Co-Investigator for  RE-DEEM at The Heart Care Clinic/CIMS (2008)

 

Randomized Dabigatran Etexilate dose finding study in patients with acute coronary syndromes post index Event with additional risk factors for cardiovascular complications also receiving aspirin and clopidogrel: Multi-centre, prospective, placebo controlled, group dose escalation trial Trial completed
21 Co-Investigator for Magellan Trial (2008) A Multicenter, Randomized, parallel-group efficacy superiority study in hospitalize medically ill patients comparing rivaroxaban with Enoxaparin Ongoing
22 Co-Investigator for Borealis Trial at The Heart Care Clinic/CIMS Ahmedabad (2008) A multicenter, randomized, double-blind, assessor-blind, non-inferiority study comparing the efficacy and safety of once-weekly subcutaneous biotinylated idraparinux (SSR126517E) with oral adjusted-dose warfarin in the prevention of stroke and systemic thromboembolic events in patient with atrial fibrillation Ongoing
23 Co-Investigator for Freedom-PAH at The Heart Care Clinic/CIMS FREEDOM UT –15C Studies (TDE-PH-302 and TDE-PH-304) conducted by United Therapeutics.

 

Ongoing
24 Co-Investigator for ORBIT – 1 Pilot study to evaluate the safety & performance or the diamond back 360TM orbit Atherectomy system in treating de-NOVO calcified coronary lesions – orbit -1 Trial completed
25 Co-Investigator for AVERROES at The Heart Care Clinic/CIMS CV 185-048: A Phase 3, Active (Aspirin) Controlled, Randomized, Double-Blind, Parallel arm Study to Evaluate the Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillation Ongoing
26 Co-Investigator for Red-HF at The Heart Care Clinic/CIMS A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects with Symptomatic Left Ventricular Systolic Dysfunction  and Anemia – 20050222 Amendment 1. Ongoing
27 Co-Investigator for TAK-442-202 at The Heart Care Clinic/CIMS A Phase II, double-blind, Randomized, Placebo-controlled study of the safety and Efficacy of TAK-442 in subjects with Acute Coronary Syndrome. Trial completed
28 Co-Investigator for EISAI-202 at The Heart Care Clinic/CIMS A Randomized, Double-Blind Placebo controlled study of the safety and tolerability of E5555 and its effect on clinical event and biomarkers in patient with Non ST segment Elevation Acute Coronary Syndrome. Trial completed
29 Co-Investigator for E-Resolute at the Heart Care Clinic/CIMS Evaluation of the Endeavor Resolute Zolarolumes-Eluting Coronary Stent System in a ‘Real World’ Patient Population. Follow-up ongoing
30 Co-Investigator of RIVAROXABAN at The Heart Care Clinic/CIMS Randomized, Double Blind, Placebo Controlled, Event Driven, Multi Center Study To Evaluate The Efficacy And Safety Of Rivaroxaban In Subjects With Recent ACS. Ongoing
31 Co-Investigator of Pfizer PAH at The Heart Care Clinic/CIMS  B1321001 A Phase 3, Multi Center, Randomized, Double Blind, Placebo Controlled, Safety And Efficacy Study Of Sitaxsentan Sodium In Subjects With Pulmonary Arterial Hypertension. Ongoing
32 Co-Investigator of Pfizer PAH at The Heart Care Clinic/CIMS

B1321002

A Phase 3, Multi Center, Open Label Study To Evaluate The Long Term Safety Of Monotherapy Sitaxsentan Sodium And Combination Therapy With Sitaxsentan Sodium And Sildenafil Citrate In Subjects With Pulmonary Arterial Hypertension. Ongoing
33 Co-Investigator of Pfizer PAH at The Heart Care Clinic/CIMS

B1321003

A Phase 3, Multi Center, Randomized, Double Blind, Efficacy And Safety Study Of Monotherapy Sitaxsentan Sodium Versus Combination Therapy With Sitaxsentan Sodium and Sildenafil Citrate In Subjects With Pulmonary Arterial Hypertension Who Have Completed Study B1321001. Ongoing
34 Co-Investigator of LPL STABILITY at The Heart Care Clinic/CIMS A Clinical Outcome Study Of Darapladib Versus Placebo In Subjects With Chronic Coronary Heart Disease To Compare The Incidence Of Major Adverse Cardiovascular Event. (MACE) Ongoing
35 Co-Investigator of OASIS-8 at The Heart Care Clinic/CIMS A Prospective Study Evaluating The Safety Of Two Regimens Of Adjustive Intravenous UFH PCI In High Risk Patients With UA/NSTEMI Initially Treated With Subcutaneous Fondaparinux And Referred For Early Coronary Angiography. Ongoing
36 Principal-Investigator of STEM CELL A Randomized, Double Blind, Multi Centric, Placebo Controlled, Single Dose, Phase I/II Study Assessing The Safety And Efficacy Of Intravenous Ex Vivo Cultured Adult Allogenic Mesenchymal Stem Cell In Patients With ST Elevated Acute MI  (STEMI) Patient. Ongoing
37 Co-Investigator for RUBY 1Trial at The Heart Care Clinic /CIMS  Ahmedabad (2010) A Randomized, Double Blind, Placebo Controlled, Multi Center

and Parallel Group Study of the Safety, Tolerability, and Efficacy

of YM150 in combination with  Standard Treatment in Secondary

Prevention of Ischemic Vascular Events in Subjects with Acute

Coronary Syndromes.

Ongoing
38 Co-Investigator for AmarinTrial at The Heart Care Clinic/CIMS Ahmedabad (2010) A phase 3, multi center, placebo controlled, randomized, double blind,

12 week study with an open label extension to evaluate the efficacy

And safety of AMR101 in patients with fasting triglyceride levels

> 500 mg/dl and < 2000 mg/dl.

Ongoing
39 Co-Investigator for AmarinTrial at The Heart Care Clinic/CIMS Ahmedabad (2010) A Phase III, Randomized, Double Blind, Evaluation Of The Safety And Efficacy Of Apixaban In Subjects With A Recent Acute Coronary Syndrome. Ongoing
40 Co-Investigator for SASHF RTrial at The Heart Care Clinic/CIMS Ahmedabad (2008) South Asian Systolic Heart Failure Registry Ongoing
41 Principal Investigator for TRAC HF Trial at The Heart Care Clinic/CIMS Ahmedabad (2009) TRAC HF: Ambulatory Monitoring Using External Physiological Sensors in Heart Failure Patients. Trial Completed
42 Co-Investigator for DOT HF Trial at The Heart Care Clinic/CIMS Ahmedabad (2009) DOT-HF- Diagnostic Outcome Trial in Heart Failure Trial Completed
43 Co-Investigator for T BEST D Trial at The Heart Care Clinic/CIMS Ahmedabad (2009) T-BEST-D: Temporary Bronchial Epicardial Stimulation –  Defibrillation Clinical Study Version dated: June 28, 2009 Trial Completed
44 Co-Investigator for ALECARDIO Trial at The Heart Care Clinic/CIMS Ahmedabad (2010) A phase 3 multicenter, randomized, double-blind, parallel group,  placebo controlled Study  ardiovascular outcome study to evaluate the  otential of aleglitazar to reduce cardiovascular risk

in patients with a recent acute coronary syndrome (ACS) event and type 2 diabetes mellitus (T2D)

Ongoing
45

 

Co  Investigator for TIMI 52 Trial at The Heart Care Clinic / CIMS Ahmedabad (2010)

 

A phase 3 multicenter, randomized, double-blind, parallel group,  placebo controlled Study of Darapladib versrsus Placebo in Subject Following Acute Coronary Syndrome  to compare the Incidence of Major Adverse Cardiovascular Events Ongoing
46 Co  Investigator for SOLISTICE trial at CIMS Hospital

Ahmedabad (2011)

A Randomized ,double-blind,placebo-controlled study yo evaluate the safety of 12 weeks of dosing with GW856553 and its effects on inflammatory markers,infaraction without ST segment elevation ongoing
47 Co Investigator for  CANVAS study atCIMS Hospital

Ahmedabad (2011)

A Randonriz-ed. Doublc-lllintl. I’arallt’1.

Placebo-Controlled, Multicenter Study of the Effects of JNJ-28431754 t-rn Cardiovascular Outcotrte: Adult Subjects With Type 2 Diabetes Mellitus. The CANVAS Trial (CANaglil’lozin CardioVascular

Assessment Study)

 

ongoing
48 Co Investigator of study ATTAIN at CIMS Hospital Ahmedabad (2011) a prospective, non-randomized, multi-center, post-market, global clinical trial to assess left-heart lead implant and complication rate using the Medtronic Attain Family of left-heart leads and delivery catheters.

 

ongoing
49 Co  Investigator  for TIMI 53 / CIMS Hospital Ahmedabad(2011) A Multicentre, Randomized, Double-Blinded, Placebo-Controlled Phase IV Trial to Evaluate the effect of Sexagliptin on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischemic Stroke inn patient with Type 2 Diabetes)

 

ongoing
50 Co Investigator of study OPTIMIND at CIMS Hospital Ahmedabad (2011) Clinical Outcome of Pacemaker pallents

according to pacing Modality and primary INDications

ongoing
51 Co Investigator of study  SST at CiMS Hospital Ahmedabad(2011) The Painfree SST (Smart ShockTechnology) clinical Study.

 

ongoing

NATIONAL CLINICAL TRIALS 

1 Co – Investigator  for BIVAFLO Registy (2006) To evaluate the efficacy and safety of BIVAFLO® as an

adjunctive therapy during PCI in moderate-high risk

ACS patients with provisional GP IIb/IIIa inhibitors use.

Trial completed
2 Co – Investigator  for CORREL + C  Trial (2006) The COREL C  Registry : A multicentre Post marketing Survelliance

for clinical and angiographic evaluation of Corel C stent

Trial completed
3 Co-Investigator for POLYCAP Trial A randomized double blind controlled trial of the efficacy

And safety of POLYCAP Vs its components in subjects

With atleast one additional cardiovascular risk factor

Trial completed
4 Co – Investigator for ACUNOVA Trial (2006-2007) A phase III, open label, multicentric, parallel group,

Randomized study to evaluate the safety and efficacy of

Abciximab in Indian patients scheduled for Percutaneuos

Coronary Intervention.

Trial completed
5 Co – Investigator for ZYHI Trial at The Heart Care Clinic Ahmedabad (2007) (1) A randomized, double blind parallel group, prospective dose rangingstudy of  ZYH 1 with an open fenofibrate arm to evaluate the efficacy

on dyslipidemia in patients without diabetes  Protocol No. 2001 Ver: 01

(2) A randomized, double blind parallel group, prospective dose ranging study of ZYH1 with an open pioglitazone arm to evaluate the efficacy

on dyslipidemia in patients with diabetes Protocol No. 2003  Ver: 02

(3) A randomized, double blind parallel group, prospective dose ranging

study of  ZYH 1 with an open pioglitazone arm to evaluate the efficacy

on dyslipidemia in patients with impaired glucose test Protocol No.2004  Ver: 02                                   

 

 

Trial completed
PROCEDURES DONE ASSISTED
 Congenital Echo >10000                      –
 Adult Echo/TEE >10000
Coronary angiogram/cath >10000 112
PTCA >5000 231
BMV/BPV/BAV/Coactoplasty >500 103/9/6/6
ASD/PDA Device closure >100 19/7
Temporary Pacemaker

Implantation

 >1000 31
Permanent Pacemaker

Implantation

>200 50
PTA >100 55

References:

1.Dr Gilles Montalescot

Institut De Cardiologie

Department De Cardiologie Medicale

Assistance Public Hopitaux

PITIE-SALPETRIERE University Hopital

50/52, Bouleverd Vincent Auriol

75651  PARIS CEDEX 13 FRANCE

2.Dr. V. Jacob Jose, MD DM(Card), FCCP MS(USA) FACC

Head and Professor of Department of Cardiology,

Christian Medical College and Hospital,

Vellore 632 004

Tamil Nadu – INDIA

 

3.Dr. George Joseph, MD DM(Card)

Head and Professor of Department of Cardiology, Unit I

Christian Medical College and Hospital,

Vellore 632 004

Tamil Nadu – INDIA

Web Design MymensinghPremium WordPress ThemesWeb Development

CIMS GlobL Healthcare Excellence Awards 2018

October 30, 2018
CIMS Family is honoured to be the recipient of “Among Best Hospital (Cardiology & Oncology) in Gujarat” on October 27, 2018 at the “Prime Time Global Healthcare Excellence Awards 2018”, New Delhi. A very special thanks to our CIMS Staff for their commitment and the patients who have always trusted us. CIMS GlobL Healthcare Excellence Awards 2018

CIMS Hospital has been awarded the Certificate of Excellence as the Best Multispecialty Hospital in Gujarat

August 31, 2018
We proudly announce that CIMS Hospital has been awarded the Certificate of Excellence as the Best Multispecialty Hospital in Gujarat at the International Healthcare Awards, 2018 held in Delhi. The Award is a testimony to the hard work and dedication of the entire CIMS Family which has inspired trust in us leading to rising patient volumes.

Certificate course in EMG & NCV Technology

May 15, 2018

Renal Transplant (CIMS/RIC/2018/09) on 15/05/2018

May 15, 2018
Renal Transplant is done on 15/05/2018, which was approved by Hospital based Ethical committee and Government Authorization committee. Relationship between Donor and Recipient : Wife - Husband

We are proud to announce that CIMS Hospital has been recognized as the Times Health Icon 2018 in 2 categories

March 19, 2018
We are proud to announce that CIMS Hospital has been recognized as the Times Health Icon 2018 in 2 categories Multispecialty Hospital- Oncology and Multispecialty Hospital-Critical Care.

CIMS Heart Transplant Team completes another successful Heart Transplant on 06-02-2018, 5th row in a short term.

February 8, 2018

Felicitation Ceremony of Heart Transplant Donors and Recipients held in the presence of Honorable Chief Minister of Gujarat, Shri Vijay Rupani, CIMS cardiac and heart tranplantation doctors by CIMS Hospital.

January 12, 2018
Felicitation Ceremony of Heart Transplant Donors and Recipients held in the presence of Honorable Chief Minister of Gujarat, Shri Vijay Rupani, CIMS cardiac and heart tranplantation doctors by CIMS Hospital.